Liver Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 7, 2006; 12(25): 3977-3982
Published online Jul 7, 2006. doi: 10.3748/wjg.v12.i25.3977
Figure 2
Figure 2 Effects of αIR3 on in vitro growth of HepG2 cells treated with various concentrations of αIR3 for different periods of time. αIR3 of 0.1 μg/mL could stimulate HepG2 cells to proliferate, while αIR3 inhibited HepG2 cell proliferation in a dose- and time-dependent manner at a concentration ranging from 0.2 μg/mL to 4.0 μg/mL.